Terrence Blaschke
Director/Board Member bei DURECT CORPORATION
Vermögen: 3 751 $ am 31.03.2024
Profil
Terrence F.
Blaschke is an Independent Director at DURECT Corp.
since 2006 and a Professor-Medicine & Molecular Pharmacology at Stanford University School of Medicine since 1974.
He previously worked as a Director at Therapeutic Discovery Corp.
and Crescendo Pharmaceuticals Corp.
Additionally, he served as Vice President-Methodology & Science at Pharsight Corp.
from 2000 to 2002.
Dr. Blaschke holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Denver.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DURECT CORPORATION
0,01% | 26.03.2024 | 3 100 ( 0,01% ) | 3 751 $ | 31.03.2024 |
Aktive Positionen von Terrence Blaschke
| Unternehmen | Position | Beginn |
|---|---|---|
| DURECT CORPORATION | Director/Board Member | 01.12.2006 |
| Stanford University School of Medicine | Corporate Officer/Principal | 01.01.1974 |
Ehemalige bekannte Positionen von Terrence Blaschke
| Unternehmen | Position | Ende |
|---|---|---|
Pharsight Corp.
 Pharsight Corp. Packaged SoftwareTechnology Services Pharsight's products and services help drugmakers build and shape their pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets. | Corporate Officer/Principal | 01.01.2002 |
Crescendo Pharmaceuticals Corp.
 Crescendo Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Crescendo Pharmaceuticals Corp. develops pharmaceutical products. The company is headquartered in Mountain View, CA. | Director/Board Member | - |
Therapeutic Discovery Corp.
 Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Director/Board Member | - |
Ausbildung von Terrence Blaschke
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Denver | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Health Technology |
Crescendo Pharmaceuticals Corp.
Crescendo Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Crescendo Pharmaceuticals Corp. develops pharmaceutical products. The company is headquartered in Mountain View, CA. | Health Technology |
Pharsight Corp.
Pharsight Corp. Packaged SoftwareTechnology Services Pharsight's products and services help drugmakers build and shape their pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets. | Technology Services |
